Invictus RG (Singapore)’s West Pharmaceutical WST Stock Holding History

Invictus RG (Singapore)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-206	Closed	-$11K	–	431
2015 Q3	$11K	Sell	206 -15	-7%	-$874	0.01%	550
2015 Q2	$13K	Buy	+221	New	+$12.3K	0.01%	519
2014 Q3	–	Sell	-235	Closed	-$10K	–	756
2014 Q2	$10K	Buy	+235	New	+$10.1K	0.01%	634
2013 Q4	–	Sell	-4,268	Closed	-$176K	–	699
2013 Q3	$176K	Buy	+4,268	New	+$163K	0.15%	255

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Invictus RG (Singapore)'s WST Position: Q4 2015 in Review

Invictus RG (Singapore) sold out of West Pharmaceutical (WST) in Q4 2015, closing a stake of 206 shares — an estimated $11K sold.

Invictus RG (Singapore) first reported a position in WST in Q3 2013 and held it in 4 quarters. The position peaked at $176K in Q3 2013. 249 funds tracked by Wall St. Rank hold WST as of Q4 2015.

Invictus RG (Singapore) reported no remaining West Pharmaceutical position as of Q4 2015 after selling out during the quarter.
Invictus RG (Singapore) sold 206 West Pharmaceutical shares in Q4 2015, an estimated $11K.
Invictus RG (Singapore) first reported a position in West Pharmaceutical in Q3 2013 and held it in 4 quarters.
Invictus RG (Singapore)'s West Pharmaceutical position peaked at $176K in Q3 2013.
249 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2015.

Based on Invictus RG (Singapore)'s 13F filing for Q4 2015.